Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Blueprint Medicines Corporation

Clinical trials sponsored by Blueprint Medicines Corporation, explained in plain language.

Now part of Sanofi S.A. SNY NASDAQ

A precision medicine company developing targeted therapies for cancer and rare diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 6 Not yet finished but already full! 2 Completed 4 Terminated 1

New cancer drug BLU-222 tested in early trial – but study stopped early

Disease control Terminated

This early-phase trial tested a new drug called BLU-222, alone or with other medicines, in about 50 people with advanced solid tumors (including certain breast, ovarian, and stomach cancers). The goal was to find a safe dose and see if it shrinks tumors. However, the study was te…

Phase: PHASE1 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC